Cybin Inc.: Cybin to Participate at the Pathways to Access S

- Amir Inamdar, Chief Medical Officer, to appear on panel discussions on June 5 and June 8 - - Ellen James, Director, Clinical Development, to present abstract titled "SPL026 (DMT fumarate) in combination

Related Keywords

Amsterdam , Noord Holland , Netherlands , United Kingdom , United States , Canada , Haarlem , Ireland , American , Kellen James , Gabriel Fahel , Samir Inamdar , Exchange Commission , Health Canada , Linkedin , Youtube , Instagram , Clinical Development , Interdisciplinary Conference On Psychedelic Research , Drug Administration , Cybin Inc , Chief Medical Officer , Major Depressive , Interdisciplinary Conference , Psychedelic Research , Marketing Approval , Psychedelics Designing Trials , Access Summit , Chief Medical , Major Depressive Disorder , Generalized Anxiety Disorder , Breakthrough Therapy Designation , Cboe Canada , Legal Officer , Ihr Portfolio ,